Clinical Trial

Natural History of MADD

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to conduct a longitudinal, observational investigation to determine the natural history of Multiple Acyl-CoA Dehydrogenase Deficiency (MADD), delineate the spectrum of its clinical features and their progression, identify biomarkers, and develop and validate patient reported outcomes.
Trial Details
NCT Number NCT07734090
Lead Sponsor Icahn School of Medicine at Mount Sinai
Conditions Multiple Acyl-CoA Dehydrogenase Deficiency
Enrollment 50 participants
Start Date 2026-07
Primary Completion 2031-07 (estimated)
Study Completion 2031-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-29